The commitment to the Zeiss Convivo brand is there, importantly, it will be a critical part of a suite of "advanced surgical certainty" products. CZM is not a company that sets out its wares, with high production value videos, with a view to failure.
The cheapest and easiest way forward for CZM will be to buy Optiscan and the associated IP. Wishful thinking? Time will tell.
"Optiscan’s optical fibre confocal microscope patents will expire in July and August 2009, while the patents over the miniaturised scanning systems provide for significant extended protection through to 2019".
well here it is, page-8
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $137.8M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.5¢ | 15.5¢ | $20.87K | 130.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 35000 | 15.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.25pm 08/10/2024 (20 minute delay) ? |
| OIL (ASX) Chart |